Patents by Inventor John M. McIver

John M. McIver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200330479
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: March 3, 2020
    Publication date: October 22, 2020
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20190175475
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: July 10, 2018
    Publication date: June 13, 2019
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 9877908
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: January 30, 2018
    Assignee: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20170348214
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: January 18, 2017
    Publication date: December 7, 2017
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20170239160
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 24, 2017
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 9675539
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: June 13, 2017
    Assignee: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 9579270
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: February 28, 2017
    Assignee: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20160220467
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Application
    Filed: April 14, 2016
    Publication date: August 4, 2016
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 9346837
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: May 24, 2016
    Assignee: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20160106651
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: December 3, 2015
    Publication date: April 21, 2016
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20150238469
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: October 8, 2014
    Publication date: August 27, 2015
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 8906962
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: December 9, 2014
    Assignee: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20140099268
    Abstract: A method for treating hair loss in mammals uses compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. Compositions containing 2-decarboxy-2-phosphinico prostaglandin derivatives can also be used to lower intraocular pressure and treat bone disorders.
    Type: Application
    Filed: December 6, 2013
    Publication date: April 10, 2014
    Applicant: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Publication number: 20140024587
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: Duke University
    Inventors: Mitchell A. deLong, John M. McIver, Robert S. Youngquist
  • Patent number: 5582762
    Abstract: Aqueous liquid detergent compositions are described which comprise a proteolytic enzyme wherein the proteolytic activity is reversibly inhibited by a peptide trifluoromethyl ketone.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: December 10, 1996
    Assignee: The Procter & Gamble Company
    Inventors: Regine Labeque, John M. McIver, Christiaan A. J. K. Thoen
  • Patent number: 5576283
    Abstract: Aqueous liquid detergent compositions are described which comprise a proteolytic enzyme wherein the proteolytic activity is reversibly inhibited by a peptide aldehyde.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: November 19, 1996
    Assignee: The Procter & Gamble Company
    Inventors: James P. Johnston, Regine Labeque, Pierre M. A. Lenoir, Christiaan A. J. K. Thoen, John M. McIver